glutathione and pulmonary hypertension New Drugs Therapies in Arterial Pathophysiology of Group 3 Pulmonary
Pathophysiology of Group 3 Pulmonary Hypertension Associated with Lung Diseases and or Hypoxia Strategizing Drug Therapies in Pulmonary Hypertension for Improved Outcomes Frontiers Mitochondria in hypoxic pulmonary hypertension, roles and the potential targets Molecular regulation and therapeutic implications of cell death in pulmonary hypertension Cell Death Discovery
Pay in 4 interest-free payments of $6.85 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13



